Anyone have additional DD on $RVVTF (Revive Therapeutics) repurposing of Bucillamine (anti-rheumatic) for COVID treatment?
March 22, 2022 at 10:55 AM EDT
Hi folks. Disclaimer, I currently have a position in $RVVTF but I’m looking to bolster my research before perhaps taking a larger position. I know the FDA let Revive SKIP Phase II and go straight to Phase III trials but I’m not well-versed in the science behind this. I rely on folks in the biotech […]